Unclear if Chronic Cough Drug Has Meaningful Benefit, FDA Reviewers Say

(MedPage Today) -- It remains "unclear" whether the modest effects of gefapixant, an investigational drug for chronic cough, represent a clinically meaningful benefit, said FDA staff ahead of a meeting of the agency's Pulmonary-Allergy Drugs Advisory...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news